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Abstract The perception of visceral pain is a complex process involving the spinal cord and
higher order brain structures. Increasing evidence implicates the gut microbiota as a key regulator
of brain and behavior, yet it remains to be determined if gut bacteria play a role in visceral
sensitivity. We used germ-free mice (GF) to assess visceral sensitivity, spinal cord gene expression
and pain-related brain structures. GF mice displayed visceral hypersensitivity accompanied by
increases in Toll-like receptor and cytokine gene expression in the spinal cord, which were
normalized by postnatal colonization with microbiota from conventionally colonized (CC). In GF
mice, the volumes of the anterior cingulate cortex (ACC) and periaqueductal grey, areas involved in
pain processing, were decreased and enlarged, respectively, and dendritic changes in the ACC
were evident. These findings indicate that the gut microbiota is required for the normal visceral
pain sensation.
DOI: 10.7554/eLife.25887.001
Introduction
Accumulating evidence indicates that the gut microbiota communicates with the central nervous sys-
tem (CNS) in a bidirectional manner thereby influencing brain function and behavior (Sampson and
Mazmanian, 2015; Dinan and Cryan, 2012; Mayer, 2011). Although the majority of studies investi-
gating the effects of the microbiota on brain function involve animal models of anxiety, depression,
and cognitive dysfunction, it is now becoming clear that the gut microbiota may also have a role in
other CNS-related conditions, such as visceral pain (O’Mahony et al., 2014; Gareau et al., 2007;
McKernan et al., 2010).
Abdominal pain, often characterized by visceral hypersensitivity, is a common, and at times, dom-
inant symptom of several gastrointestinal disorders, including functional dyspepsia and irritable
bowel syndrome (IBS) (Enck et al., 2016). There is also a high comorbidity among visceral pain and
psychiatric disorders such as depression and anxiety (Felice et al., 2015). These painful events are
often recurring and unpredictable, which can have a debilitating impact on a person’s daily life
(Quigley, 2006). Moreover, many gastrointestinal disorders with visceral pain as a component lack
an identifiable pathology and can be difficult to treat with current pharmaceuticals, many of which
are associated with undesirable side effects (Wood, 2013; Moloney et al., 2016).
The perception of visceral pain is a complex process involving peripheral sensory nerves, and, in
the CNS, spinal and cortical pathways as well as areas associated with integration of the experience
of pain (Apkarian et al., 2005). Pathological pain states have been associated with altered neuroim-
mune signaling and glial activation in the spinal cord (Ji et al., 2013; Grace et al., 2014). In the
brain, there is a significant overlap in areas regulating the affective component of visceral pain and
those mediating psychological stress, a major predisposing factor for visceral hypersensitivity
(Larauche et al., 2012). Imaging studies in humans with IBS (Tillisch et al., 2011; Mertz et al.,
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2000) and in animal models of visceral hypersensitivity (Gibney et al., 2010; Felice et al., 2014;
Bliss et al., 2016) have revealed increased activation in the medial prefrontal cortex (mPFC) in
response to both viscerally painful and stressful stimuli.
Numerous studies now indicate that the perception of visceral pain can by influenced by the
intestinal microbiota. In rodent studies, specific bacterial strains (probiotics) have been shown to
ameliorate visceral pain induced by stress (Gareau et al., 2007; McKernan et al., 2010; Ait-
Belgnaoui et al., 2006) or antibiotic administration (Verdu´ et al., 2006), and many probiotics have
been shown to benefit humans with abdominal pain (Clarke et al., 2012). Intriguingly, visceral hyper-
sensitivity can be transferred via the microbiota of IBS patients to animals previously lacking
microbes (Crouzet et al., 2013). However, the mechanisms underlying the effects of the microbiota
on visceral pain perception remain to be elucidated.
Integrating these observations, this study is based on the hypothesis that the microbiota is
required for the normal processing of visceral pain stimuli. To this end, we used germ-free mice (GF;
mice raised without any exposure to microorganisms) to study pain-related behavior, genes, and
brain structures. We first studied visceral sensitivity, expression of cytokines, Toll-like receptors
(TLRs), and glial markers in the spinal cord, and mPFC morphology in these animals. Secondly, we
determined if postnatal microbial colonization could normalize visceral hypersensitivity and immune
status within the spinal cord of GF mice.
Results
Animals
Four cohorts of animals were used to perform the experiments in this paper. Animals in the first
cohort (CC = 10, GF = 9; Figure 1) underwent CRD and then were euthanized. Animals in the sec-
ond cohort (CC and GF = 9–10; Figure 2) were sacrificed without anesthesia and spinal cord tissue
eLife digest The human gut is home to over 100 trillion microbes collectively known as the gut
microbiota. These microbes help us to digest food and absorb the nutrients effectively. A diverse
and stable community of gut microbes is believed to be important for good health. Recently, it has
also become clear that the microbiota can also influence the brain and how we behave. For
example, many studies suggest that gut microbiota can alter how an individual perceives pain, but it
is not clear how this works.
Rodents are often used in experiments as models of human biology. One of the most frequently
used rodent models in studies of gut microbes is the “germ-free” mouse. These mice grow up in
laboratory environments that are completely free of microbes, making it possible to study how
having no gut microbes affects the health and behaviour of the mice. Luczynski, Tramullas et al. used
germ-free mice to study how the gut microbiota influences an animal’s sensitivity to pain.
The experiments show that, compared to mice with normal gut microbiota, the germ-free mice
were more sensitive to pain from internal organs especially the gut. These mice also produced larger
amounts of specific proteins involved in immune responses, which contributed to the animal’s
increased sensitivity to pain. Allowing the germ-free mice to be colonised with gut microbes could
reverse these changes.
The experiments also show that the germ-free mice had changes in the size of two areas of the
brain involved in sensing pain: an area called the anterior cingulate cortex was smaller, while the
periaqueductal grey region was enlarged. There were also differences in individual nerve cells within
the anterior cingulate cortex compared to normal mice.
The findings of Luczynski, Tramullas et al. reinforce the idea that the gut microbiota is involved in
the sensation of pain from internal organs, and show that hypersensitivity to this form of pain can be
reversed later in life by colonising the gut with microbes. Continuing to study the impact of
microbes on this type of pain could aid the development of new therapies for the treatment of pain
disorders in humans.
DOI: 10.7554/eLife.25887.002
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was collected to perform gene expression analyses. Animals in the third cohort (CC = 20, GF = 20,
GFC = 10; Figures 5, 6 and 7) underwent CRD and spinal cord tissue was collected. Animals in the
fourth cohort (CC = 17, GF = 18; Figures 3 and 4, and Figure 4—figure supplement 1) were eutha-
nized without undergoing any procedures. See Materials and methods for more details.
Does growing up GF alter visceral sensitivity, pain-related genes, and
CNS morphology?
Visceral hypersensitivity in GF mice
When compared to controls, GF mice showed increased visceral pain responses (main effect of pres-
sure: F4,60 = 76.75, p<0.001; main effect of group: F1,15 = 12.51, p=0.0030; Figure 1A). Post hoc
analyses revealed that GF mice displayed visceral hypersensitivity at pressures of 10, 40, 65, and 80
mmHg (Figure 1—figure supplement 1A). Representative CRD traces at the pressure of 40 mmHg
and 65 mmHg for conventional or GF mice are shown in Figure 1—figure supplement 1B–E. Impor-
tantly, in line with our previous studies (O’Mahony et al., 2012), there was no significant difference
in the basal activity (between distensions) of the abdominal musculature between groups
(F1,15 = 0.38, p=0.58) or within the same experimental group (F4,60 = 1.08, p=0.374). The visceral
pain threshold was significantly lower in GF versus CC mice (t17 = 2.12, p=0.049; Figure 1B).
Altered TLR and cytokine gene expression in the spinal cord of GF mice
In GF mice, the transcription levels of TLR1 (t18 = 2.92, p=0.0093), TLR2 (t17 = 2.56, p=0.020), TLR3
(t18 = 2.81, p=0.012), TLR4 (t18 = 2.38, p=0.029), TLR5 (t17 = 3.16, p<0.0057), TLR7 (t17 = 2.49,
p=0.023), TLR9 (t16 = 2.22, p=0.041), and TLR12 (t13 = 2.55, p=0.024) were significantly increased in
the lumbosacral spinal cord compared to controls (Figure 2A–H). No changes were observed in the
expression of TLR6 (CC = 0.027 ± 0.0022, GF = 0.034 ± 0.0036, t18 = 1.54, p=0.14), TLR8
(CC = 0.018 ± 0.0021, GF = 0.023 ± 0.0022, t18 = 1.65, p=0.12), and TLR11 (CC = 1.00 ± 0.37,
GF = 0.86 ± 0.41, t7 = 0.26, p=0.81).
In GF mice, there was also a significant increase in the transcription levels of IL6 (t17 = 2.80,
p=0.012), IL10 (t17 = 2.11, p=0.050), TNFa (t17 = 2.80, p=0.0015), IL1a (t16 = 2.27, p=0.038), and
Figure 1. Visceral hypersensitivity in GF mice. Visceral sensitivity to colorectal distention (CRD; ascending
paradigm from 10 to 80 mm Hg) was assessed as the number of visceromotor responses (VMR) over pressures. (A)
GF mice displayed increased visceral pain responses compared to controls. (B) The pain threshold was lower in GF
compared to CC mice. In this and subsequent figures, *p0.05, **p<0.01, and ***p<0.001 versus CC animals. CC,
n = 10; GF, n = 9.
DOI: 10.7554/eLife.25887.003
The following figure supplement is available for figure 1:
Figure supplement 1. Schematic illustration showing the ascending phasic distension paradigm (10–80 mmHg) (A)
and representative CRD traces at the pressure of 40 mmHg and 65 mmHg for conventional (B,C) or germ-free (D,
E) mice. The paradigm consists of three repeated pulses at each pressure level, with a pulse duration of 20 s at 5-
min intervals.
DOI: 10.7554/eLife.25887.004
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IL1b (t15 = 2.74, p=0.016) compared to CC mice. However, no changes were observed in the expres-
sion levels of IFNg (t18 = 0.31, p=0.76), IL12a (t18 = 0.30, p=0.77), and IL12b (t18 = 0.75, p=0.46;
Figure 2I–P).
Figure 2. Increased Toll-like receptor and cytokine gene expression in the spinal cord of GF mice. (A–H) Gene
expression levels of the Toll-like receptors TLR1 (A), TLR2 (B), TLR3 (C), TLR4 (D), TLR5 (E), TLR7 (F), TLR9 (G), and
TLR12 (H) were significantly elevated in the spinal cord of GF versus CC mice. (I–M) When compared to controls,
GF mice showed increased gene expression levels of the cytokines IL6 (I), TNFa (J), IL10 (K), IL1a (M), and IL1b (N).
There was no change in the gene expression of the cytokines IFNg (L), IL12a (O), and IL12b (P). CC, n = 9–10; GF,
n = 9–10.
DOI: 10.7554/eLife.25887.005
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Figure 3. Reduction in ACC and increase in PAG volume in GF mice. (A,C,E), Representative thionin-stained section of the mPFC (A), cortex (C), and
PAG (E). The volumes of the defined (black lines) subregions of interest were estimated using Cavalieri’s principle. Scale bars = 0.5 mm. (B) In GF mice,
the volume of the ACC was reduced. (D) Cortical volume did not differ between CC and GF mice. (F) The PAG was larger in GF versus CC mice. CC,
n = 5; GF, n = 6–7.
DOI: 10.7554/eLife.25887.006
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Figure 4. Basilar dendritic elongation in ACC pyramidal neurons of GF mice. (A,B,C) Representative images of Golgi-stained layer II/III pyramidal
neurons of CC and GF mice (A). Neurons were reconstructed in 3D using morphometric software (B). Sholl analysis was performed on 2D renderings of
the neurons (incremental radii from the soma are indicated by the color gradient; C). Scale bars = 50 mm. (D) There was no group difference in the
topographical location (i.e. cell layer) of the neurons in the ACC. (E) When compared to controls, the dendrites of ACC pyramidal neurons of GF mice
were longer. This elongation was principally localized to the basilar dendritic arbor. (F) There was no change in the number of branch points of ACC
pyramidal neurons between groups. (G) Sholl analysis of the total dendritic arbor revealed no difference in dendritic complexity between CC and GF
Figure 4 continued on next page
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Altered volume of pain-related brain structures of GF mice
We compared the volumes of the mPFC subregions in CC versus GF mice (Figure 3A and B). The
anterior cingulate cortex (ACC) was 21% smaller in GF mice compared to controls (t10 = 2.78,
p=0.020). There were no significant differences in the volumes of the prelimbic (PL) and infralimbic
(IL) cortices between groups (PL: t10 = 0.90, p=0.39; IL: t10 = 1.56, p=0.15).
To determine if the reduction in ACC volume observed in GF mice extended to the rest of the
cortex, we measured cortical volume (Figure 3C and D). Total cortical volume was not significantly
different in CC and GF mice (t9 = 0.77, p=0.46).
We measured periaqueductal grey (PAG) volume to determine if brain regions in the descending
pain modulation pathway were affected by microbial status (Figure 3E and F). The PAG was 22%
larger in GF compared to CC mice (t9 = 3.83, p=0.0040).
Dendritic hypertrophy of ACC pyramidal neurons of GF mice
Dendritic morphology
Morphometric analyses were performed on the dendrites of Golgi-stained layer II/III ACC pyramidal
neurons (Figure 4A–I). There was no significant difference in the distance from the pia for neurons
from CC and GF mice (t8 = 0.96, p=0.36; Figure 4D), indicating that neurons from both groups
were located in similar topographical locations (i.e. cell layer) in the ACC. There was no statistically
significant difference in total dendritic length (t8 = 2.28, p=0.052; Figure 4E) or the number of
branch points (t8 = 0.59, p=0.57; Figure 4F) between groups. The basilar dendrites of GF mice were
22% longer than controls, but there was no significant change in apical dendritic length (apical:
t8 = 1.72, p=0.12; basilar: t8 = 2.65, p=0.029; Figure 4E). There was no significant group difference
in the number of branch points in either apical or basilar dendrites (apical: t8 = 0.73, p=0.49; basilar:
t8 = 0.39, p=0.71; Figure 4F).
2D Sholl analysis revealed no significant group differences in ACC pyramidal neuron total den-
dritic distribution (main effect F1, 8 = 2.16, p=0.18; interaction F14, 112 = 1.43, p=0.15; Figure 4G).
We then conducted more specific Sholl analyses, investigating the complexity of the apical and basi-
lar dendritic arbors separately. Sholl analysis revealed a significant interaction of group (CC vs GF)
and distance from the soma on the distribution of apical dendrites (F14, 112 = 3.06, p<0.001); how-
ever, post hoc comparisons uncovered no statistically significant dendritic regions in which the
change in complexity occurred (Figure 4H). There was no significant difference in the complexity of
the basilar dendrites (main effect F1, 8 = 3.29, p=0.11; interaction F14, 112 = 0.67, p=0.80; Figure 4I).
Spine density and subtype analysis
The spine subtypes and density of each layer II/III ACC pyramidal neuron was determined by sam-
pling both apical and basilar dendritic segments (Figure 4—figure supplement 1A–I). There was no
significant difference in spine width on any portion of the dendritic arbor (overall: t8 = 0.16, p=0.88;
apical: t8 = 0.16, p=0.88; basilar: t8 = 0.16, p=0.88; Figure 4—figure supplement 1D). Similarly,
there was no significant group difference in spine length overall, on apical or basilar dendrites (over-
all: t8 = 0.23, p=0.82; apical: t8 = 0.38, p=0.72; basilar: t8 = 0.83, p=0.43; Figure 4—figure supple-
ment 1E). The overall spine density (includes all spine subtypes) was 26% higher in GF mice
(t8 = 3.46, p=0.0085; Figure 4—figure supplement 1F). This increase in spines occurred on all por-
tions of the dendritic arbor: spine density was increased by 23% and 31% on apical and basilar den-
drites, respectively (apical: t8 = 3.22, p=0.012; basilar: t8 = 3.11, p=0.014; Figure 4—figure
supplement 1F). GF mice had 20% more thin spines overall on ACC pyramidal neurons compared
to controls (t8 = 2.50, p=0.037; Figure 4—figure supplement 1G). This increase in thin spines
Figure 4 continued
mice. (H) In GF mice, the apical dendritic arbor showed altered dendritic complexity; however, post hoc comparisons revealed no statistically significant
distances in which this change occurred. (I) There was no group difference in the complexity of basilar dendrites. For both CC and GF mice, n = 5.
DOI: 10.7554/eLife.25887.007
The following figure supplement is available for figure 4:
Figure supplement 1. Increase of thin and stubby spines on ACC pyramidal neurons of GF mice.
DOI: 10.7554/eLife.25887.008
Luczynski et al. eLife 2017;6:e25887. DOI: 10.7554/eLife.25887 7 of 21
Research article Microbiology and Infectious Disease Neuroscience
appears to be principally located on basilar dendrites: there was a strong trend toward an increase
in thin spines on basilar dendrites but no such effect on apical dendrites (apical: t8 = 1.73, p=0.13;
basilar: t8 = 2.20, p=0.060; Figure 4—figure supplement 1G). In GF mice, the overall stubby spine
density was increased by 53% compared to controls (t8 = 3.30, p=0.011; Figure 4—figure supple-
ment 1H). The higher stubby spine density was located to the basilar dendritic arbor: the basilar
dendrites of GF mice had 69% more stubby spines while there was no change in apical stubby spine
density (apical: t8 = 2.04, p=0.076; basilar: t8 = 4.77, p=0.0014; Figure 4—figure supplement 1H).
There was no significant group difference in mushroom spine density on any portion of the dendritic
arbor (overall: t8 = 1.55, p=0.16; apical: t8 = 1.53, p=0.16; basilar: t8 = 1.53, p=0.16; Figure 4—fig-
ure supplement 1I). Finally, there was no group difference in filopodia spine density overall, or on
apical and basilar dendrites (overall: CC = 0.041 ± 0.0067, GF = 0.065 ± 0.015, t8 = 1.43, p=0.19;
apical: CC = 0.037 ± 0.010, GF = 0.065 ± 0.016, t8 = 1.43, p=0.19; basilar: CC = 0.044 ± 0.0051,
GF = 0.065 ± 0.014, t8 = 1.33, p=0.22).
Does microbial colonization normalize visceral hypersensitivity, spinal
cord TLR and cytokine expression in GF mice?
Reversal of visceral hypersensitivity in GF mice following microbial
colonization
To determine whether microbial colonization later in life could reverse the visceral hypersensitivity
observed in GF mice, a cohort of GF mice were exposed to feces from CC mice. Microbial coloniza-
tion normalized visceral pain perception in response to colonic stimulation (main effect of pressure:
F4,68 = 33.42, p<0.001; main effect of group: F2,17 = 11.85, p<0.001; Figure 5A). The pain threshold
was also normalized in GFC mice (F2,25 = 4.56, p=0.021; Figure 5B).
Normalization of gene expression in the spinal cord of GF mice following
microbial colonization
GFC animals displayed normalized gene expression levels of TLR1 (F2,46 = 7.35, p=0.0018), TLR2
(F2,45 = 5.77, p=0.0060), TLR4 (F2,47 = 6.05, p=0.0047), TLR5 (F2,45 = 3.98, p=0.026), TLR7
(F2,44 = 6.96, p=0.0024), and TLR12 (F2,45 = 4.64, p=0.015). Although microbial colonization normal-
ized the expression levels of TLR3 (F2,45 = 4.04, p=0.025) and TLR9 (F2,46 = 3.54, p=0.038) in relation
to CC mice, no significant differences were observed between GFC and GF mice (Figure 6A–H).
Similarly, microbial colonization normalized the gene expression levels of IL6 (F2,27 = 6.12,
p=0.0068), TNFa (F2,42 = 4.38, p=0.019), and IL10 (F2,43 = 6.01, p=0.0050). Microbial colonization
normalized the expression of IL1a (F2,46 = 3.52, p=0.038) and IL1b (F2,37 = 7.10, p=0.0026)
Figure 5. Normalization of visceral hypersensitivity following colonization of GF mice. (A,B) Microbial colonization
restored normal visceral pain responsivity (A) and pain threshold (B). For this and subsequent figures, *p<0.05,
**p<0.01, and ***p<0.001 versus CC mice; $p < 0.05; $$p < 0.01 versus GFC mice. CC, n = 10; GF, n = 8; GFC,
n = 9.
DOI: 10.7554/eLife.25887.009
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Figure 6. Normalization of toll-like receptor and cytokine gene expression in the spinal cord of GF mice following
microbial colonization. (A–H) Microbial colonization normalized the increased gene expression levels of the toll-
like receptors TLR1 (A), TLR2 (B), TLR4 (D), TLR5 (E), TLR7 (F), and TLR12 (H) observed in the spinal cord of GF
mice. No changes were observed in the expression levels of TLR3 (C) and TLR9 (G) between GFC and GF mice. (I–
M) Microbial colonization reversed the elevated gene expression of the cytokines IL6 (I), TNFa (J), and IL10 (K) in
the spinal cord of GF mice. No changes were observed in the expression levels of IL1a (L) and IL1b (M) between
GFC and GF mice. (N) No group changes were observed in the expression levels of TRPV1. CC, n = 16–20; GF,
n = 15–20; GFC, n = 7–10.
DOI: 10.7554/eLife.25887.010
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compared to controls; however, there was no statistical difference between GFC and GF mice
(Figure 6I–M). In addition, gene expression levels of TRPV1 were measured. No significant changes
were observed between groups (F2, 20 = 0.28, p=0.7621; Figure 6N).
Reversal of astrocyte and microglial activation in the spinal cord of GF mice
following microbial colonization
Because TLRs are predominantly expressed on astrocytes and microglia within the CNS
(Lehnardt et al., 2003), we investigated the relationship between glia and the enhanced gene
expression of several TLRs in the spinal cord. Similarly to TLRs, protein levels of GFAP and Cd11b,
respective markers of astrocyte and glial activation (Yao et al., 2014; Bignami et al., 1972), were
increased in the spinal cord of GF versus CC mice. Importantly, microbial colonization normalized
Figure 7. Normalization of glial activation and cytokine protein expression in spinal cord of GF mice following microbial colonization. Western blot
analysis was performed for GFAP (astrocyte marker) and Cd11b (microglial marker) in the lumbosacral region of the spinal cord in CC, GF, and GFC
mice. (A,B), The increased expression of both GFAP (A) and CD11b (B) in GF mice was normalized following colonization. (C–E) ELISA assays were
performed to assess the protein levels of cytokines. Microbial colonization similarly normalized the elevated protein levels of the cytokines IL6 (C) and
TNFa (D) in the spinal cord. However, no change was observed in the expression of IL10 (E) between GFC and GF mice. CC, n = 5–11; GF, n = 6–10;
GFC, n = 4–8.
DOI: 10.7554/eLife.25887.011
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the protein levels of GFAP (F2,17 = 79.6, p<0.001; Figure 7A) and CD11b (F2,19 = 47.47, p<0.001;
Figure 7B) to control levels.
Normalization of protein levels of cytokines in the spinal cord of GF mice
following microbial colonization
We measured protein levels of cytokines to confirm that the microbiota was regulating their expres-
sion in the spinal cord. Expression levels of IL6 (F2,23 = 4.70, p=0.021, Figure 7C) and TNFa
(F2,24 = 4.79, p=0.019; Figure 7D) were significantly increased in GF mice compared to CC mice and
normalized following the microbial colonization. Although microbial colonization returned the pro-
tein expression of IL10 to baseline in relation to CC mice (F2,23 = 3.74, p=0.041, Figure 7E), no sig-
nificant differences were observed between GFC and GF mice. The values for IL1a and IL1b were
below detection range. No significant differences were observed in the levels of expression of IL12
(CC: 0.6341 ± 0.158, GF: 0.8422 ± 0.142, GFC: 0.7896 ± 0.121, F2, 21 = 0.58, p=0.57) and IFNg (CC:
0.0141 ± 0.0038, GF: 0.1271 ± 0.0013, GFC: 0.0137 ± 0.0041, F2, 24 = 0.19, p=0.82) between
groups.
Discussion
The aim of this study was to determine if commensal gut bacteria are required for normal visceral
sensitivity and CNS pain processing. Our results show that mice raised in GF conditions exhibited
visceral hypersensitivity and an increase in cytokine and TLR expression in the spinal cord. We have
also demonstrated that postnatal microbial colonization normalizes the visceral hypersensitivity and
spinal cord inflammatory profile of GF mice. In addition, we found that these animals had increased
ACC and decreased PAG volumes as well as dendritic hypertrophy of single pyramidal neurons in
the ACC. Taken together, these results clearly indicate that the gut microbiota is required for normal
visceral nociception and pain processing at the level of the CNS.
The microbiota and visceral pain
This study adds proof-of-principle evidence to the growing body of support for an association
between the gut microbiota and visceral nociception (Eisenstein, 2016). We have previously shown
that exposure to stressors or antibiotic treatment in early life can have enduring effects on visceral
pain in rodents, and these effects are accompanied by a change in microbial composition
(O’Mahony et al., 2014, 2009). Moreover, in rodents, probiotics can ameliorate visceral pain
induced by stress (Gareau et al., 2007; McKernan et al., 2010; Ait-Belgnaoui et al., 2006) or anti-
biotic administration (Verdu´ et al., 2006), and even exert an inhibitory influence on visceral sensitiv-
ity in healthy rats (Kamiya et al., 2006). Clinical studies have repeatedly found that the composition
of the gut microbiota is altered in patients with IBS (Collins, 2014; Jeffery et al., 2012) and that
patients suffering from abdominal pain can benefit from probiotic treatment (Clarke et al., 2012).
Although these studies report an association between altered microbial composition and visceral
pain processing, the impact of the microbiota cannot be separated from other factors, such as stress
or antibiotic side effects. In this set of experiments, we use GF as a tool to show that visceral sensi-
tivity is heightened in mice in the absence of any microbiota.
Although it is now clear that the gut microbiota plays a role in visceral nociception, the exact
mechanism by which the microbiota exerts its influence on the CNS remains unknown. It is likely that
many systems simultaneously contribute to the altered nociception in GF mice, including immune,
neural, endocrine, and metabolic processes (Sampson and Mazmanian, 2015; Dinan and Cryan,
2012; Mayer, 2011; Luczynski et al., 2016; Cryan and Dinan, 2012). Indeed, GF mice have blunted
immune function and altered TLR expression in the gut (Shanahan, 2002; Clarke et al., 2013). Inter-
estingly, the development in early life and function of the enteric nervous system (ENS) in adulthood
is altered in GF mice (Collins et al., 2014; McVey Neufeld et al., 2013). Enteric sensory neurons
synapse with vagal nerve endings in the gut (Perez-Burgos et al., 2014), providing a direct route
whereby the intestinal bacterial status can be communicated to the brain. Growing up germ-free
heightens hypothalamic-pituitary-adrenal axis responsivity, which is thought to occur via a neuronal
mechanism (Sudo et al., 2004). GF rodents also have a reduced production of short chain fatty acids
(den Besten et al., 2013), which are metabolites produced by gut bacteria thought to be key
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mediators of gut-brain signaling. Moving forward, it would be interesting to determine if is it the cell
surface proteins on intact bacteria or their metabolites and other products that are involved in
changes along the brain-gut axis.
Spinal cord signaling of visceral pain
Within the gastrointestinal tract, nociceptors respond to many stimuli including stretch, pH, bacterial
products, immune signaling molecules, and neurotransmitters released from the ENS or from the
bacteria themselves (Sengupta, 2009). From the gut, nociceptive signals are transmitted to the spi-
nal cord, and subsequently the brain. Recent evidence has implicated neuroimmune and spinal
microglial mechanisms in chronic visceral pain (Ji et al., 2013; Grace et al., 2014; Bradesi, 2010).
TLR receptor signaling is also involved in visceral nociception and IBS pathology (Tramullas et al.,
2014, Tramullas et al., 2016). Moreover, microglial structure and homeostasis are disrupted in both
GF and antibiotic-treated mice (Erny et al., 2015), indicating that the microbiota is required for nor-
mal microglial function in the CNS. Microglia can be activated through TLR signaling, and once acti-
vated, increase the secretion of various cytokines (Bradesi, 2010). In the present study, we report
that glial activation, TLR expression, and cytokine signaling are all increased in the lumbosacral spi-
nal cord of GF mice, an area associated with signals from the colon. Indeed, microglial activation
(Saab et al., 2006), reduced glutamate-reuptake by astrocytes (Gosselin et al., 2010), and increased
TLR signaling (Tramullas et al., 2014) in the spinal cord have been previously shown in rodent mod-
els with visceral hypersensitivity.
TRPV1 receptors are broadly expressed in the gastrointestinal tract and many areas of the CNS,
including the spinal cord and is well-recognized as a transducer of noxious stimuli (Nagy et al.,
2004). We found no changes in the mRNA expression of the TRPV1 receptor in the GF spinal cord.
This result is in line with previous data from our group showing that the colon of GF mice exhibits
the same responsiveness to capsaicin (a TRPV1 agonist) relative to controls (Lomasney et al., 2014),
suggesting no change in the expression of the TRPV1 receptor. In contrast, rats exposed to vanco-
mycin in early in life resulting in an altered gut microbiome, show enhanced visceral pain perception
and a decrease in spinal cord TRPV1 expression (O’Mahony et al., 2014). In the gut, TRPV1 recep-
tors play a key role in pain perception (Holzer, 2011); however, TRPV1 signaling does not appear to
be responsible for the visceral hypersensitivity observed in GF mice. Further studies are required to
confirm changes in the expression of TRPV1 receptor in other areas of the CNS involved in visceral
pain perception. With regard to what influences the changes in cytokines and TLRs in the spinal cord
of GF mice we can speculate that lack of certain metabolites and or short chain fatty acids which
reduce visceral pain or exaggerated sensation in a conventional mouse are not present to gate the
pain signals which can lead to altered signaling in the spinal cord. Moreover, GF are known to have
an altered immune system and hence changes in spinal cord immune players fits well with the
literature.
Prefrontal cortical structural changes and visceral pain
The affective or emotional component of pain is mediated by the ACC (Apkarian et al., 2005). Stud-
ies in humans with IBS (Tillisch et al., 2011; Mertz et al., 2000) and in animal models (Gibney et al.,
2010; Felice et al., 2014; Bliss et al., 2016) have revealed increased activation in the mPFC in
response to visceral pain. In addition, imaging studies have consistently observed reduced cortical
grey matter in patients with IBS (Davis et al., 2008). Although cortical structure has yet to be investi-
gated in animal models of visceral pain, rodents with long-lasting neuropathic pain show a reduction
of ACC volume (Seminowicz et al., 2009) and basilar dendritic hypertrophy of pyramidal neurons
(Metz et al., 2009). We report a remarkably similar reduction in ACC volume in GF mice as well as
elongation of single ACC pyramidal neurons. Importantly, GF mice showed no difference in mush-
room spines, which represent mature, long-lasting postsynaptic connections (Matsuzaki et al.,
2004). Instead, the density of ‘immature’ thin and stubby spines was higher in these animals. These
results can be interpreted as a microbiota-induced deficit in synaptic pruning resulting in the hyper-
activity of ACC neurons. Such changes in ACC signaling would likely impact visceral sensitivity, as
this area receives and sends projections to many pain-relevant brain areas including the limbic sys-
tem, ventral tegmental area and the PAG (Hoover and Vertes, 2007).
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The neurons in the PAG, once activated are involved in an endogenous pain inhibitory system
(Apkarian et al., 2011). It is currently unclear what the relative contribution of the altered PAG vol-
ume is to the visceral hypersensitivity behavior observed in GF mice. The PAG receives signals from
cortical areas such as the ACC where this connection is thought to mediate expectation and placebo
analgesia (Petrovic et al., 2002). Hence, input changes from the ACC may have a reciprocal effect
on the PAG. What is evident, however, is that both cortical and subcortical pain pathways are
altered in GF mice. Taken together, our results suggest that gross morphological and ultrastructural
changes in the ACC and PAG could underlie the visceral hypersensitivity observed in GF mice.
Conclusions
Our results show that the gut microbiota dramatically impacts visceral sensitivity and affects signal-
ing in key structures involved in the processing and integration of painful stimuli. These results fur-
ther reinforce the idea that the microbial composition of mice in conventional facilities may affect
the responsiveness to CRD (Verdu´ et al., 2006). Importantly, this maladaptive pain responsivity is
amenable to microbial-based interventions in later life. This is noteworthy as numerous postnatal col-
onization experiments have been performed in GF mice, with certain behavioral and physiological
changes proving reversible (Clarke et al., 2013; Sudo et al., 2004; Diaz Heijtz et al., 2011) and
others irreversible (Desbonnet et al., 2014; Stilling et al., 2015). Hence the addition of colonization
experiments with regard to morphological measures would be of interest in future studies. More-
over, we find across a number of different domains that the effects of the microbiome on brain and
behavioural are much more robust in males than females (Clarke et al., 2013; Desbonnet et al.,
2015; Hoban et al., 2016). Therefore, future analysis of visceral sensitivity in female animals is
indeed worthy of investigation. Improving our understanding of the impact of microbiota on visceral
pain sensitivity (O’Mahony et al., 2017) may ultimately inform novel therapies for the treatment of
gastrointestinal pain disorders.
Materials and methods
Animals
Swiss Webster breeding pairs for both GF and CC mice were supplied by Taconic (Germantown,
New York, USA) and first-generation male offspring were studied in all experiments. In the University
College Cork GF Unit, GF mice were group housed in flexible film gnotobiotic isolators maintained
at 21 ± 1˚C, with 55–60% relative humidity, under a 12 hr light/dark cycle. A group of GF mice were
colonized (GFC) on postnatal day 21 with microbiota obtained from CC mice. Briefly, GF mice were
removed from the GF facility and allowed to grow to adulthood in the conventional animal facility in
cages with bedding and fecal matter from CC mice, a method which has previously been shown to
effectively restore a normal microbiota (Clarke et al., 2013; Desbonnet et al., 2014;
O’Connell Motherway et al., 2011). CC and GFC mice were group housed in the standard animal
facility which was held at the same controlled conditions and light/dark cycle as the GF mice. GF,
CC, and GFC mice were age-matc and fed the same autoclaved pelleted diet (Special Diets Services,
product code 801010) and were housed 2–5 per cage (only one group of CC mice was housed two
per cage). Animals were tested or euthanized at 5–10 weeks of age. All experiments were per-
formed in accordance with the guidelines of European Directive 86/609/EEC and the Recommenda-
tion 2007/526/65/EC and were approved by the Animal Experimentation Ethics Committee of
University College Cork.
Four cohorts of animals were used to perform the experiments in this paper. Animals in the first
cohort (CC = 10, GF = 9; Figure 1) underwent CRD and then were euthanized. No samples were col-
lected from this cohort. Animals in the second cohort (CC and GF = 9–10; Figure 2) were sacrificed
without anesthesia and spinal cord tissue was collected to perform gene expression analyses. These
mice were not exposed to CRD. After data analysis, we decided that it would be of interest to deter-
mine if bacterial colonization could rescue the visceral hypersensitivity and associated changes noted
in GF mice from the first and second cohorts. With the third cohort of mice (CC = 20, GF = 20, GFC
= 10; Figures 5, 6 and 7)), we repeated the CRD and collected the spinal cord tissue. Due to the
limited number of GFC mice available, most GFC animals used in the spinal cord analysis had been
exposed to CRD. However, we verified that there was no statistical difference between those
Luczynski et al. eLife 2017;6:e25887. DOI: 10.7554/eLife.25887 13 of 21
Research article Microbiology and Infectious Disease Neuroscience
animals that underwent CRD and those that did not in the CC and GF groups. Animals in the fourth
cohort (CC = 17, GF = 18; Figures 3 and 4, and 4 supplement 1) were euthanized without undergo-
ing any procedures. Brain tissue from 10 animals from each group was processed for Golgi-Cox
staining and the remainder of the brains were processed as per the stereology protocol.
Colorectal distention (CRD)
CRD was carried out as previously described (O’Mahony et al., 2012; Tramullas et al., 2012). The
CRD-system was composed of a barostat (Distender Series II, G and J Electronics, Toronto, ON,
Canada) and a transducer amplifier (LabTrax 4, World Precision Instruments, Sarasota, FL). A cus-
tom-made balloon (2 cm length x 1 cm inflated diameter) prepared from a polyurethane plastic bag
(GMC Medical, Denmark) was tied over a PE60 catheter with silk 4.0. Before securing the balloon to
the catheter, several holes were punched in the distal 20 mm of the tubing with a 27-gauge needle
to allow the balloon to inflate.
On the experimental day, mice were lightly anesthetized with isoflurane (2% vapor in oxygen; Iso-
Flo, Abbott, UK) and a lubricated balloon with a connecting catheter was inserted into the colon, 0.5
cm proximal to the anus. The catheter was fixed to the base of the tail with tape to avoid any dis-
placement. Unrestrained mice were allowed to recover for 10 min before starting the CRD proce-
dure. The balloon was connected to the barostat system and subsequent pressure changes within
the distending balloon, observed in response to a distension paradigm, were monitored and
recorded using Data Trax two software (World Precision Instruments, Sarasota, FL). The ascending
phasic distension (from 10 to 80 mmHg) paradigm, consisting of three 20 s pulses at each pressure
and 5-min inter-pulse intervals, was used. The visceromotor responses (VMR) were quantified as
pressure changes observed within the colonic distending balloon during the colorectal distension
procedure. VMR were calculated as the average of the three consecutive pulses for each pressure.
Additionally, for each animal, pain threshold was defined as the pressure which exceeded the mean
baseline activity plus three times the standard deviation (see Figure 1-supplement 1A 4 for phasic
stages). At the end of the experiments, the balloon was carefully removed and the animals were
returned to their home cages.
Spinal cord analysis
Sample collection
Mice were sacrificed without anesthesia, the spinal cord was extracted by hydro-extrusion, and the
dorsal root ganglia were removed (Lantero et al., 2014). The lumbosacral region of the spinal cord
was dissected, snap-frozen and stored at  80˚C. The lumbosacral segments of the spinal cord
receive input from visceral afferents originating from the colon (Kyloh et al., 2011). We did not col-
lect dorsal root ganglia or gut mucosa.
Qualitative real-time PCR
Total RNA was extracted from the spinal cord using the Qiagen RNeasy Lipid Mini Kit (QIAGEN,
Valencia, CA). RNA quality was assessed using the Agilent Bioanalyzer (Agilent, Stockport, UK)
according to the manufacturer’s procedure and an RNA integrity number (RIN) was calculated. RNA
with RIN value >7 was used for subsequent experiments. Complementary DNA was synthesized
using 1 mg total RNA using random primers. Quantitative PCR was carried out in an LightCycler480
System using specific probes (six carboxy fluorescein - FAM) designed by Applied Biosystems to
mouse specific TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TLR11, TLR12, TNFa, IL1a,
IL1b, IL6, IL10, IL12a, IL12b, IFNg, and TRPV1, while using b-Actin as an endogenous control. Data
were analyzed using the 2 DCt method and expressed as relative expression. No significant differen-
ces were observed in the mRNA expression levels of b-Actin between groups.
Western blot
Western blot was performed as previously described (Tramullas et al., 2010). Whole-cell lysates
were prepared from the lumbosacral region of the spinal cord and total protein was determined
using the Quan-iT protein assay kit (Invitrogen, Ireland). Equal amounts of protein were subjected to
electrophoresis on 4–12% gradient gels (NuPAGE, Invitrogen, Ireland) and transferred to a polyviny-
lidene difluoride membrane (Bio Rad, Ireland). Membranes were then incubated with goat anti-
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GFAP (1:1000; Sigma, Ireland), the astrocyte marker, rabbit anti-CD11b (1:500; Novus Biologicals,
UK), a microglia activation marker; and mouse anti b-actin (1:15000; Sigma, Ireland). Immunoreactiv-
ity was detected with Pierce ECL detection reagent (Thermo Scientific, IL, USA) and visualized using
a luminescent image analyzer (LAS-3000, Fujifilm, Ireland). The relative density of the immunoreac-
tive bands was quantified using Fiji Is Just ImageJ (FIJI) software (Schindelin et al., 2012) and nor-
malized to the relative density of mouse anti-b actin (Sigma, Ireland) for each sample. No significant
differences were observed in the protein expression levels of b-Actin between groups.
Cytokine assay
Measurement of cytokine levels on the spinal cord was carried out with custom mouse Multi-spot
96-well plates (Meso Scale Discovery, Rockville, MD) according to instructions of the manufacturer.
Briefly, samples were weighted, homogenized with buffer and added to pre-coated wells in dupli-
cate and incubated for 2 hr. Wells were then washed using phosphate buffered saline-Tween 20 and
incubated with an antibody mix (a-IL6, a-TNFa and a-IL10 antibodies) in diluent for 2 hr. ELISA
plates were analyzed using the Sector 2400 imager from Meso Scale Discovery. This is an ultra-sensi-
tive method which has a detection limit of 0.3 pg/ml. Data were normalized to the amount of tissue
per well and expressed as pg/mg.
Stereological measurement of brain volume
The volumes of the mPFC, total cortex, and periaqueductal grey (PAG) were estimated using Cava-
lieri’s principle (Gundersen et al., 1988). Brain structures were characterized using the Paxinos and
Franklin, 2001 atlas as a guide.
Histological preparation
Animals were terminally anesthetized with sodium pentobarbital and perfused transcardially with 0.1
м phosphate buffer, followed by 4% paraformaldehyde. Brains were postfixed in a 4% paraformalde-
hyde solution for 24 hr and then cryoprotected in a 30% sucrose solution for a further 48 hr. The brains
were flash-frozen in isopentane and stored at  80˚C. Using a cryostat, brains were coronally sectioned
at 40 mm and sections were lightly stained with thionin. All slides were coded to obscure the experi-
mental group of each animal until statistical analysis.
Analysis of medial prefrontal cortical volume
The volumes of the anterior cingulate (ACC; Cg1 + Cg2), prelimbic (PL), and infralimbic (IL) cortices
were estimated. The first rostrocaudal appearance of the corpus callosum (Bregma +1.98 mm) was
chosen as the sample starting point and its decussation was chosen as the end point (Bregma +1.10
mm). The left and right cortices were imaged separately to allow for better resolution and visualiza-
tion of cell layers and total cortical and mPFC volume were calculated by summing the hemisphere
values. For each animal, 12 to 16 evenly-spaced serial sections with a randomized start were studied
(periodicity of every slice; section increment of 0.04 mm). The region of interest was digitally out-
lined in each section (4 magnification; N.A. 0.1) and converted to area values (mm2) using FIJI soft-
ware (Schindelin et al., 2012). The area values were then combined with the cut section thickness
(0.04 mm) and section increment to compute the volumes of the prefrontal cortex subregions.
Analysis of total cortical volume
The volume of the total cortex was estimated using the boundaries previously defined by
Smiley et al. (2015). The first rostrocaudal appearance of the corpus callosum (Bregma +1.98 mm)
was chosen as the sample starting point and the termination of the hippocampus was chosen as the
end point (disappearance of the granular layer of the dentate gyrus; Bregma  4.03 mm). The analy-
sis excluded the mPFC and the orbitofrontal cortex. The left and right cortices were imaged sepa-
rately to allow for better resolution and visualization of cell layers and total cortical and mPFC
volume were calculated by summing the hemisphere values. For each brain, 24 to 30 evenly-spaced
serial sections with a randomized start were studied (periodicity of every fourth slice; section incre-
ment of 0.16 mm). The perimeter of the cortex was digitally outlined in each section (2 magnifica-
tion, N.A. 0.08) and volume was calculated. One GF mouse was excluded from cortical volumetric
analysis due to damaged tissue.
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There were no significant hemispheric differences in mPFC or total cortical volume between mice
of the same group (p>0.05 for all subregions); therefore, the sum of the left and right volumes were
used for these analyses.
Analysis of periaqueductal grey volume
The volume of the total PAG was estimated as described above. The first rostrocaudal appearance
of the nucleus of Darkschewitsch (Bregma  2.80 mm) was chosen as the sample starting point and
the termination of the PAG was the end point (Bregma  5.20 mm). The whole PAG was imaged and
analyzed. For each brain, 12 to 16 evenly-spaced serial sections with a randomized start were stud-
ied (periodicity of every third slice; section increment of 0.12 mm). The perimeter of the PAG was
digitally outlined in each section (4 magnification, N.A. 0.1) and volume was calculated. One GF
mouse was excluded from PAG volumetric analysis due to damaged tissue.
Dendritic morphology and spine density analysis
Golgi-Cox staining procedure
Animals were terminally anesthetized with sodium pentobarbital and perfused transcardially with
0.9% saline. Golgi-cox staining was performed on the whole brain using a commercially available
staining kit (Bioenno Tech, Irvine, CA). Brains were coronally sectioned at 150 mm using a vibrotome
and mounted on gelatin-coated slides. Slides were lightly stained with thionin to visualize mPFC
cytoarchitecture. All slides were coded to obscure the experimental group of each animal until statis-
tical analysis.
Analysis of dendritic morphology and spine density
The analysis of ACC pyramidal neurons was restricted to those located in cortical layers II and III. To
be included in the analysis, neurons had to fulfil the following criteria (Vyas et al., 2002): (1) the
absence of prematurely truncated dendrites, (2) dark and uniform dendritic staining, and (3) rela-
tively isolated from neighboring neurons. Three pyramidal neurons were reconstructed in each hemi-
sphere of each animal.
For the dendritic morphology analysis, the neurons were imaged using an Olympus AX70 Provis
brightfield microscope with an Olympus DP50 camera (Mason, Ireland). Images were taken at 40
magnification (N.A. 1.0) at 1 or 2 mm intervals throughout the entire section. Neurons were recon-
structed manually from color-inverted stacks using the Neurofilament tool in Imaris (Bitplane, Swit-
zerland). Total dendritic length and branching were calculated by the software. Sholl analysis, the
measurement of dendritic complexity as a function of radial distance from the soma, was performed
on 2D reconstructions using the plug-in for FIJI (Schindelin et al., 2012; Ferreira et al., 2014). The
radius step size was 20 mm.
Spine density and subtype analyses were performed on all ACC pyramidal neurons which were
reconstructed to characterize dendritic arborization. Dendritic segments (branch order 2) which
had consistent and dark impregnation were imaged at a magnification of 100 (N.A. 1.4). From
each neuron, two to three apical and basilar dendritic segments of approximately 20 mm were ana-
lyzed. Spines were classified into subtypes using RECONSTRUCT image analysis software
(Risher et al., 2014). Briefly, the length and width of each spine was measured and, based on these
measurements, spines were classified as thin (length to width ratio >1), stubby (length to width
ratio 1), mushroom (width value >0.6 mm), and filopodia (length value >2 mm). Values were calcu-
lated by averaging the spine data per neuron, and then once again for each animal. The data set
was comprised of a total of ~7100 dendritic spines from 60 neurons.
Animal means were used for all analyses of dendritic morphology and spine density. When statis-
tical significance was achieved, percentage changes were calculated with respect to control values.
Statistical analysis
The sample size was determined by a power calculation and aimed at detecting differences between
groups at the 0.05 level (Lomasney et al., 2014; Matsuzaki et al., 2004). Data are expressed as
means + or ±1 SEM. The unpaired Student’s t-test (a = 0.05) was used to compare two independent
groups (CC vs GF; right vs left hemisphere). Comparisons of more than two groups were performed
by one-way ANOVA. Group differences in the CRD and Sholl analyses were tested for significance
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with a two-way mixed design ANOVA, with pressure and radial distance from the soma as within
group factors. Post-hoc comparisons were made using a Bonferroni’s correction (p<0.05). The
Grubbs method (Grubbs, 1950) was used to test for outliers for the CRD and spinal cord analyses.
Acknowledgements
The authors are funded by Science Foundation Ireland (SFI), through the Irish Government’s National
Development Plan in the form of a centre grant (APC Microbiome Institute Grant Number SFI/12/
RC/2273), and through EU GRANT 613979 (MYNEWGUT FP7-KBBE-2013–7; JFC, TGD). The Centre
has conducted studies in collaboration with several companies including Mead Johnson, Suntory
Wellness, Cremo, Alimentary Health, 4D Pharma and Nutricia. The help of Ms. Suzanne Crotty, Ms.
Tara Foley, Mr. Alan Hoban, Ms. Frances O’Brien, Mr. Patrick Fitzgerald and Dr. Roman Stilling is
gratefully acknowledged.
Additional information
Funding
Funder Grant reference number Author
Science Foundation Ireland SFI/12/RC/2273 Fergus Shanahan
Timothy G Dinan
John F Cryan
European Commission EU GRANT 613979
(MYNEWGUT FP7-KBBE-
2013-7
Timothy G Dinan
John F Cryan
The funders had no role in study design, data collection and interpretation, or the decision to
submit the work for publication.
Author contributions
PL, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing—original
draft, Writing—review and editing; MT, Conceptualization, Data curation, Formal analysis, Investiga-
tion, Methodology, Writing—original draft, Project administration, Writing—review and editing; MV,
Formal analysis, Investigation, Methodology, Writing—review and editing; FS, Formal analysis, Writ-
ing—original draft, Project administration, Writing—review and editing; GC, Resources, Funding
acquisition, Writing—review and editing; SO, Resources, Data curation, Writing—review and editing;
TGD, Supervision, Funding acquisition, Project administration, Writing—review and editing; JFC,
Conceptualization, Supervision, Funding acquisition, Writing—original draft, Project administration,
Writing—review and editing
Author ORCIDs
Pauline Luczynski, http://orcid.org/0000-0001-6511-2271
Monica Tramullas, http://orcid.org/0000-0002-2447-8928
John F Cryan, http://orcid.org/0000-0001-5887-2723
Ethics
Animal experimentation: All experiments were performed in accordance with the guidelines of Euro-
pean Directive 86/609/EEC and the Recommendation 2007/526/65/EC and were approved by the
Animal Experimentation Ethics Committee of University College Cork
References
Ait-Belgnaoui A, Han W, Lamine F, Eutamene H, Fioramonti J, Bueno L, Theodorou V. 2006. Lactobacillus
farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction
with epithelial cell cytoskeleton contraction. Gut 55:1090–1094. doi: 10.1136/gut.2005.084194, PMID: 165075
83
Luczynski et al. eLife 2017;6:e25887. DOI: 10.7554/eLife.25887 17 of 21
Research article Microbiology and Infectious Disease Neuroscience
Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. 2005. Human brain mechanisms of pain perception and
regulation in health and disease. European Journal of Pain 9:463. doi: 10.1016/j.ejpain.2004.11.001, PMID: 15
979027
Apkarian AV, Hashmi JA, Baliki MN. 2011. Pain and the brain: specificity and plasticity of the brain in clinical
chronic pain. Pain 152:S49–S64. doi: 10.1016/j.pain.2010.11.010, PMID: 21146929
Bignami A, Eng LF, Dahl D, Uyeda CT. 1972. Localization of the glial fibrillary acidic protein in astrocytes by
immunofluorescence. Brain Research 43:429–435. doi: 10.1016/0006-8993(72)90398-8, PMID: 4559710
Bliss TV, Collingridge GL, Kaang BK, Zhuo M. 2016. Synaptic plasticity in the anterior cingulate cortex in acute
and chronic pain. Nature Reviews Neuroscience 17:485–496. doi: 10.1038/nrn.2016.68, PMID: 27307118
Bradesi S. 2010. Role of spinal cord Glia in the central processing of peripheral pain perception.
Neurogastroenterology and Motility 22:499–511. doi: 10.1111/j.1365-2982.2010.01491.x, PMID: 20236247
Clarke G, Cryan JF, Dinan TG, Quigley EM. 2012. Review article: probiotics for the treatment of irritable bowel
syndrome–focus on lactic acid bacteria. Alimentary Pharmacology and Therapeutics 35:403–413. doi: 10.1111/j.
1365-2036.2011.04965.x, PMID: 22225517
Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. 2013. The
microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent
manner. Molecular Psychiatry 18:666–673. doi: 10.1038/mp.2012.77, PMID: 22688187
Collins J, Borojevic R, Verdu EF, Huizinga JD, Ratcliffe EM. 2014. Intestinal microbiota influence the early
postnatal development of the enteric nervous system. Neurogastroenterology and Motility 26:98–107. doi: 10.
1111/nmo.12236, PMID: 24329946
Collins SM. 2014. A role for the gut microbiota in IBS. Nature Reviews Gastroenterology and Hepatology 11:
497–505. doi: 10.1038/nrgastro.2014.40, PMID: 24751910
Crouzet L, Gaultier E, Del’Homme C, Cartier C, Delmas E, Dapoigny M, Fioramonti J, Bernalier-Donadille A.
2013. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal
microbiota. Neurogastroenterology and Motility 25:e272–e282. doi: 10.1111/nmo.12103, PMID: 23433203
Cryan JF, Dinan TG. 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and
behaviour. Nature Reviews Neuroscience 13:701–712. doi: 10.1038/nrn3346, PMID: 22968153
Davis KD, Pope G, Chen J, Kwan CL, Crawley AP, Diamant NE. 2008. Cortical thinning in IBS: implications for
homeostatic, attention, and pain processing. Neurology 70:153–154. doi: 10.1212/01.wnl.0000295509.30630.
10, PMID: 17959767
den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. 2013. The role of short-chain fatty
acids in the interplay between diet, gut microbiota, and host energy metabolism. The Journal of Lipid Research
54:2325–2340. doi: 10.1194/jlr.R036012, PMID: 23821742
Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. 2014. Microbiota is essential for social development in
the mouse. Molecular Psychiatry 19:146–148. doi: 10.1038/mp.2013.65, PMID: 23689536
Desbonnet L, Clarke G, Traplin A, O’Sullivan O, Crispie F, Moloney RD, Cotter PD, Dinan TG, Cryan JF. 2015.
Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain, Behavior,
and Immunity 48:165–173. doi: 10.1016/j.bbi.2015.04.004, PMID: 25866195
Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjo¨rkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S,
Heijtz RD. 2011. Normal gut Microbiota modulates brain development and behavior. PNAS 108:3047–3052.
doi: 10.1073/pnas.1010529108, PMID: 21282636
Dinan TG, Cryan JF. 2012. Regulation of the stress response by the gut microbiota: implications for
psychoneuroendocrinology. Psychoneuroendocrinology 37:1369–1378. doi: 10.1016/j.psyneuen.2012.03.007,
PMID: 22483040
Eisenstein M. 2016. Microbiome: bacterial broadband. Nature 533:S104–S106. doi: 10.1038/533S104a,
PMID: 27191486
Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilic´-Stojanovic´ M,
Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. 2016. Irritable bowel syndrome. Nature
Reviews Disease Primers 2:16014. doi: 10.1038/nrdp.2016.14, PMID: 27159638
Erny D, Hrabeˇ de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T,
Jakobshagen K, Buch T, Schwierzeck V, Utermo¨hlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli
P, Stecher B, Amit I, Prinz M. 2015. Host microbiota constantly control maturation and function of microglia in
the CNS. Nature Neuroscience 18:965–977. doi: 10.1038/nn.4030, PMID: 26030851
Felice VD, Gibney SM, Gosselin RD, Dinan TG, O’Mahony SM, Cryan JF. 2014. Differential activation of the
prefrontal cortex and amygdala following psychological stress and colorectal distension in the maternally
separated rat. Neuroscience 267:252–262. doi: 10.1016/j.neuroscience.2014.01.064, PMID: 24513388
Felice VD, Moloney RD, Cryan JF, Dinan TG, O’Mahony SM. 2015. Visceral pain and psychiatric disorders.
Modern Trends in Pharmacopsychiatry 30:103–119. doi: 10.1159/000435936, PMID: 26436661
Ferreira TA, Blackman AV, Oyrer J, Jayabal S, Chung AJ, Watt AJ, Sjo¨stro¨m PJ, van Meyel DJ. 2014. Neuronal
morphometry directly from bitmap images. Nature Methods 11:982–984. doi: 10.1038/nmeth.3125,
PMID: 25264773
Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH. 2007. Probiotic treatment of rat pups normalises
corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 56:1522–1528.
doi: 10.1136/gut.2006.117176, PMID: 17339238
Gibney SM, Gosselin RD, Dinan TG, Cryan JF. 2010. Colorectal distension-induced prefrontal cortex activation in
the wistar-kyoto rat: implications for irritable bowel syndrome. Neuroscience 165:675–683. doi: 10.1016/j.
neuroscience.2009.08.076, PMID: 19765638
Luczynski et al. eLife 2017;6:e25887. DOI: 10.7554/eLife.25887 18 of 21
Research article Microbiology and Infectious Disease Neuroscience
Gosselin RD, O’Connor RM, Tramullas M, Julio-Pieper M, Dinan TG, Cryan JF. 2010. Riluzole normalizes early-life
stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms. Gastroenterology
138:2418–2425. doi: 10.1053/j.gastro.2010.03.003, PMID: 20226190
Grace PM, Hutchinson MR, Maier SF, Watkins LR. 2014. Pathological pain and the neuroimmune interface.
Nature Reviews Immunology 14:217–231. doi: 10.1038/nri3621, PMID: 24577438
Grubbs FE. 1950. Sample criteria for testing outlying observations. The Annals of Mathematical Statistics 21:27–
58. doi: 10.1214/aoms/1177729885
Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B,
Sørensen FB, Vesterby A. 1988. Some new, simple and efficient stereological methods and their use in
pathological research and diagnosis. APMIS 96:379–394. doi: 10.1111/j.1699-0463.1988.tb05320.x, PMID: 32
88247
Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, Claesson MJ, Clarke G, Cryan JF. 2016. Regulation of
prefrontal cortex myelination by the Microbiota. Translational Psychiatry 6:e774. doi: 10.1038/tp.2016.42,
PMID: 27045844
Holzer P. 2011. Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.
Pharmacology and Therapeutics 131:142–170. doi: 10.1016/j.pharmthera.2011.03.006, PMID: 21420431
Hoover WB, Vertes RP. 2007. Anatomical analysis of afferent projections to the medial prefrontal cortex in the
rat. Brain Structure and Function 212:149–179. doi: 10.1007/s00429-007-0150-4, PMID: 17717690
Jeffery IB, O’Toole PW, O¨hman L, Claesson MJ, Deane J, Quigley EM, Simre´n M. 2012. An irritable bowel
syndrome subtype defined by species-specific alterations in faecal Microbiota. Gut 61:997–1006. doi: 10.1136/
gutjnl-2011-301501, PMID: 22180058
Ji RR, Berta T, Nedergaard M. 2013. Glia and pain: is chronic pain a gliopathy? Pain 154 Suppl 1:S10–S28.
doi: 10.1016/j.pain.2013.06.022, PMID: 23792284
Kamiya T, Wang L, Forsythe P, Goettsche G, Mao Y, Wang Y, Tougas G, Bienenstock J. 2006. Inhibitory effects
of Lactobacillus reuteri on visceral pain induced by colorectal distension in sprague-dawley rats. Gut 55:191–
196. doi: 10.1136/gut.2005.070987, PMID: 16361309
Kyloh M, Nicholas S, Zagorodnyuk VP, Brookes SJ, Spencer NJ. 2011. Identification of the visceral pain pathway
activated by noxious colorectal distension in mice. Frontiers in Neuroscience 5:16. doi: 10.3389/fnins.2011.
00016, PMID: 21390285
Lantero A, Tramullas M, Pı´lar-Cuellar F, Valdiza´n E, Santilla´n R, Roques BP, Hurle´ MA. 2014. TGF-b and opioid
receptor signaling crosstalk results in improvement of endogenous and exogenous opioid analgesia under
pathological pain conditions. Journal of Neuroscience 34:5385–5395. doi: 10.1523/JNEUROSCI.4405-13.2014,
PMID: 24719115
Larauche M, Mulak A, Tache´ Y. 2012. Stress and visceral pain: from animal models to clinical therapies.
Experimental Neurology 233:49–67. doi: 10.1016/j.expneurol.2011.04.020, PMID: 21575632
Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. 2003. Activation of
innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway.
PNAS 100:8514–8519. doi: 10.1073/pnas.1432609100, PMID: 12824464
Lomasney KW, Houston A, Shanahan F, Dinan TG, Cryan JF, Hyland NP. 2014. Selective influence of host
Microbiota on cAMP-mediated ion transport in mouse Colon. Neurogastroenterology and Motility 26:887–890.
doi: 10.1111/nmo.12328, PMID: 24612168
Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG, Cryan JF. 2016. Growing up in a Bubble: using
Germ-Free animals to assess the influence of the gut Microbiota on brain and behavior. International Journal of
Neuropsychopharmacology 19:pyw020. doi: 10.1093/ijnp/pyw020, PMID: 26912607
Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H. 2004. Structural basis of long-term potentiation in single
dendritic spines. Nature 429:761–766. doi: 10.1038/nature02617, PMID: 15190253
Mayer EA. 2011. Gut feelings: the emerging biology of gut-brain communication. Nature Reviews Neuroscience
12:453–466. doi: 10.1038/nrn3071, PMID: 21750565
McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. 2010. The probiotic Bifidobacterium infantis 35624 displays
visceral antinociceptive effects in the rat. Neurogastroenterology and Motility 22:1029–e268. doi: 10.1111/j.
1365-2982.2010.01520.x, PMID: 20518856
McVey Neufeld KA, Mao YK, Bienenstock J, Foster JA, Kunze WA. 2013. The microbiome is essential for normal
gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterology and Motility 25:183–e88.
doi: 10.1111/nmo.12049, PMID: 23181420
Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, Kessler R. 2000. Regional cerebral activation in irritable
bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 118:842–
848. doi: 10.1016/S0016-5085(00)70170-3, PMID: 10784583
Metz AE, Yau HJ, Centeno MV, Apkarian AV, Martina M. 2009. Morphological and functional reorganization of
rat medial prefrontal cortex in neuropathic pain. PNAS 106:2423–2428. doi: 10.1073/pnas.0809897106,
PMID: 19171885
Moloney RD, Johnson AC, O’Mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF. 2016. Stress and
the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome. CNS Neuroscience and
Therapeutics 22:102–117. doi: 10.1111/cns.12490, PMID: 26662472
Nagy I, Sa´ntha P, Jancso´ G, Urba´n L. 2004. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology
and pathology. European Journal of Pharmacology 500:351–369. doi: 10.1016/j.ejphar.2004.07.037,
PMID: 15464045
Luczynski et al. eLife 2017;6:e25887. DOI: 10.7554/eLife.25887 19 of 21
Research article Microbiology and Infectious Disease Neuroscience
O’Mahony SM, Dinan TG, Cryan JF. 2017. The gut microbiota as a key regulator of visceral pain. PAIN 158
Suppl 1:S19–S28. doi: 10.1097/j.pain.0000000000000779, PMID: 27918315
O’Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F, Claesson MJ, O’Brien F, Flynn K, Casey
PG, Munoz JA, Kearney B, Houston AM, O’Mahony C, Higgins DG, Shanahan F, Palva A, de Vos WM,
Fitzgerald GF, Ventura M, O’Toole PW, et al. 2011. Functional genome analysis of Bifidobacterium breve
UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor.
PNAS 108:11217–11222. doi: 10.1073/pnas.1105380108, PMID: 21690406
O’Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, Woznicki J, Hyland NP, Shanahan F,
Quigley EM, Marchesi JR, O’Toole PW, Dinan TG, Cryan JF. 2014. Disturbance of the gut Microbiota in early-
life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in
male rats. Neuroscience 277:885–901. doi: 10.1016/j.neuroscience.2014.07.054, PMID: 25088912
O’Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EM, Cryan JF, Dinan TG. 2009. Early life
stress alters behavior, immunity, and Microbiota in rats: implications for irritable bowel syndrome and
psychiatric illnesses. Biological Psychiatry 65:263–267. doi: 10.1016/j.biopsych.2008.06.026, PMID: 18723164
O’Mahony SM, Tramullas M, Fitzgerald P, Cryan JF. 2012. Rodent models of colorectal distension. Current
Protocols in Neuroscience Chapter 9:Unit 9.40. doi: 10.1002/0471142301.ns0940s61, PMID: 23093353
Paxinos G, Franklin KBJ. 2001. Mouse Brain in Stereotaxic Coordinates. Academic Press.
Perez-Burgos A, Mao YK, Bienenstock J, Kunze WA. 2014. The gut-brain Axis rewired: adding a functional vagal
nicotinic "sensory synapse". The FASEB Journal 28:3064–3074. doi: 10.1096/fj.13-245282, PMID: 24719355
Petrovic P, Kalso E, Petersson KM, Ingvar M. 2002. Placebo and opioid analgesia– imaging a shared neuronal
network. Science 295:1737–1740. doi: 10.1126/science.1067176, PMID: 11834781
Quigley EM. 2006. Changing face of irritable bowel syndrome. World Journal of Gastroenterology 12:1. doi: 10.
3748/wjg.v12.i1.1, PMID: 16440408
Risher WC, Ustunkaya T, Singh Alvarado J, Eroglu C, Alvarado S. 2014. Rapid golgi analysis method for efficient
and unbiased classification of dendritic spines. PLoS One 9:e107591. doi: 10.1371/journal.pone.0107591,
PMID: 25208214
Saab CY, Wang J, Gu C, Garner KN, Al-Chaer ED. 2006. Microglia: a newly discovered role in visceral
hypersensitivity? Neuron Glia Biology 2:271–277. doi: 10.1017/S1740925X07000439, PMID: 18496611
Sampson TR, Mazmanian SK. 2015. Control of brain development, function, and behavior by the microbiome.
Cell Host and Microbe 17:565–576. doi: 10.1016/j.chom.2015.04.011, PMID: 25974299
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S,
Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source
platform for biological-image analysis. Nature Methods 9:676–682. doi: 10.1038/nmeth.2019, PMID: 22743772
Seminowicz DA, Laferriere AL, Millecamps M, Yu JS, Coderre TJ, Bushnell MC. 2009. MRI structural brain
changes associated with sensory and emotional function in a rat model of long-term neuropathic pain.
NeuroImage 47:1007–1014. doi: 10.1016/j.neuroimage.2009.05.068, PMID: 19497372
Sengupta JN. 2009., Canning B. J, Spina D (Eds). Sensory Nerves. Springer. p. 31–74.
Shanahan F. 2002. The host-microbe interface within the gut. Best Practice and Research Clinical
Gastroenterology 16:915–931. doi: 10.1053/bega.2002.0342, PMID: 12473298
Smiley JF, Saito M, Bleiwas C, Masiello K, Ardekani B, Guilfoyle DN, Gerum S, Wilson DA, Vadasz C. 2015.
Selective reduction of cerebral cortex GABA neurons in a late gestation model of fetal alcohol spectrum
disorder. Alcohol 49:571–580. doi: 10.1016/j.alcohol.2015.04.008, PMID: 26252988
Stilling RM, Ryan FJ, Hoban AE, Shanahan F, Clarke G, Claesson MJ, Dinan TG, Cryan JF. 2015. Microbes and
neurodevelopment–absence of Microbiota during early life increases activity-related transcriptional pathways in
the amygdala. Brain, Behavior, and Immunity 50:209–220. doi: 10.1016/j.bbi.2015.07.009, PMID: 26184083
Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y. 2004. Postnatal microbial colonization
programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of Physiology 558:
263–275. doi: 10.1113/jphysiol.2004.063388, PMID: 15133062
Tillisch K, Mayer EA, Labus JS. 2011. Quantitative meta-analysis identifies brain regions activated during rectal
distension in irritable bowel syndrome. Gastroenterology 140:91–100. doi: 10.1053/j.gastro.2010.07.053,
PMID: 20696168
Tramullas M, Dinan TG, Cryan JF. 2012. Chronic psychosocial stress induces visceral hyperalgesia in mice. Stress
15:281–292. doi: 10.3109/10253890.2011.622816, PMID: 21992065
Tramullas M, Finger BC, Dinan TG, Cryan JF. 2016. Obesity takes its toll on visceral pain: high-fat diet induces
toll-like receptor 4-dependent visceral hypersensitivity. PLoS One 11:e0155367. doi: 10.1371/journal.pone.
0155367, PMID: 27159520
Tramullas M, Finger BC, Moloney RD, Golubeva AV, Moloney G, Dinan TG, Cryan JF. 2014. Toll-like receptor 4
regulates chronic stress-induced visceral pain in mice. Biological Psychiatry 76:340–348. doi: 10.1016/j.
biopsych.2013.11.004, PMID: 24331544
Tramullas M, Lantero A, Dı´az A, Morcho´n N, Merino D, Villar A, Buscher D, Merino R, Hurle´ JM, Izpisu´a-
Belmonte JC, Hurle´ MA. 2010. BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor)
reveals the involvement of the transforming growth factor-beta family in pain modulation. Journal of
Neuroscience 30:1502–1511. doi: 10.1523/JNEUROSCI.2584-09.2010, PMID: 20107078
Verdu´ EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F,
Collins SM. 2006. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut
55:182–190. doi: 10.1136/gut.2005.066100, PMID: 16105890
Luczynski et al. eLife 2017;6:e25887. DOI: 10.7554/eLife.25887 20 of 21
Research article Microbiology and Infectious Disease Neuroscience
Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. 2002. Chronic stress induces contrasting patterns of
dendritic remodeling in hippocampal and amygdaloid neurons. Journal of Neuroscience 22:6810–6818.
PMID: 12151561
Wood JD. 2013. Taming the irritable bowel. Current Pharmaceutical Design 19:142–156. doi: 10.2174/
13816128130119, PMID: 22950498
Yao H, Ma R, Yang L, Hu G, Chen X, Duan M, Kook Y, Niu F, Liao K, Fu M, Hu G, Kolattukudy P, Buch S. 2014. MiR-9
promotes microglial activation by targeting MCPIP1.Nature Communications 5:4386. doi: 10.1038/
ncomms5386, PMID: 25019481
Luczynski et al. eLife 2017;6:e25887. DOI: 10.7554/eLife.25887 21 of 21
Research article Microbiology and Infectious Disease Neuroscience
